CanNordic a/s: Financial statements 2023
CVR: 33871902
Source: annual report 2023, Danish Business Authority
01/10/2022 – 30/09/2023
CanNordic a/s (CVR 33871902) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -3,918,902 and a net result of DKK -8,240,440 compared with DKK -4,299,257 the year before. Equity in the 2023 report amounted to DKK 400,327. The solvency ratio was 2.1%. The company had 7 employees in the financial year.
- Gross Profit
- DKK -3,918,902
- Profit/Loss
- DKK -8,240,440
- Equity
- DKK 400,327
- Total Assets
- DKK 18,968,771
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -3.9 mio. | -8.2 mio. | 400 t. | 7 |
| 2022 | - | 503 t. | -4.3 mio. | 641 t. | 5 |
| 2021 | 3.2 mio. | 2.4 mio. | 1.5 mio. | 1.9 mio. | 4 |
| 2020 | - | 775 t. | -46 t. | 47 t. | 2 |
| 2019 | - | 211 t. | -178 t. | -1.8 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of September 20, 2023, Alexandre Fevre has left the board of directors of CanNordic a/s.
CanNordic a/s has published its annual report for 2022. Gross profit came to DKK 502,674, and the net result was DKK -4,299,257.
As of April 14, 2023, Stein Arve Løkstad has left the board of directors of CanNordic a/s.
About CanNordic a/s
CanNordic a/s is a Danish company of the type Aktieselskab based in København Ø, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named GALAXA PHARMA ApS. The management consists of Lone Henriksen. The board consists of Gitte Henriksen, Jens Jørgen Hagelskjær and Lone Henriksen. The company is owned by CS MEDICA a/s. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK -100,395 and a net result of DKK -6,219,720 compared with DKK -4,881,640 the year before. Equity in the 2025 report amounted to DKK 4,298,968.